ArthroCare completes Opus acquisition
This article was originally published in The Gray Sheet
Executive Summary
Coblation technology developer finalizes $130 mil. purchase of soft tissue orthopedic repair system maker Opus Medical Nov. 15 (1"The Gray Sheet" Sept. 13, 2004, p. 14). ArthroCare expects Opus to generate $16 mil.-$17 mil. in 2004 revenue from AutoCuff anchoring system sales...
You may also be interested in...
Bipolar RF Sales Injunction Vacated In Appeals Decision On ArthroCare Case
Smith & Nephew is evaluating whether to re-enter the bipolar radiofrequency (RF) market now that a sales injunction has been lifted by a Washington, D.C. federal appeals court
ArthroCare/Opus integration ahead of schedule
Coblation RF tissue removal tech developer will complete the transition of Opus Medical's manufacturing operations into its Costa Rica facility during the first half of 2005 following the Nov. 15 purchase of the soft tissue orthopedic repair system maker (1"The Gray Sheet" Nov. 22, 2004, In Brief). During the fourth quarter, ArthroCare brought Costa Rica's Opus production on line and completed planned distribution changes for Opus and Coblation product lines. ArthroCare's preliminary Q4 results include revenue of $42.7 mil., up 31.4%...
ArthroCare Rounds Out Rotator Cuff Offerings With $130 mil. Opus Acquisition
ArthroCare plans to introduce Opus Medical's AutoCuff anchoring system for bankart repair and slap procedures in early 2005